These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 23963041
1. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia. Audia S, Samson M, Mahévas M, Ferrand C, Trad M, Ciudad M, Gautheron A, Seaphanh F, Leguy V, Berthier S, Salles B, Martin L, Lorcerie B, Ortega-Deballon P, Facy O, Caillot D, Soudry-Faure A, Michel M, Godeau B, Larmonier N, Saas P, Janikashvili N, Bonnotte B. Blood; 2013 Oct 03; 122(14):2477-86. PubMed ID: 23963041 [Abstract] [Full Text] [Related]
2. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Audia S, Samson M, Guy J, Janikashvili N, Fraszczak J, Trad M, Ciudad M, Leguy V, Berthier S, Petrella T, Aho-Glélé S, Martin L, Maynadié M, Lorcerie B, Rat P, Cheynel N, Katsanis E, Larmonier N, Bonnotte B. Blood; 2011 Oct 20; 118(16):4394-400. PubMed ID: 21876120 [Abstract] [Full Text] [Related]
3. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia. Audia S, Rossato M, Trad M, Samson M, Santegoets K, Gautheron A, Bekker C, Facy O, Cheynel N, Ortega-Deballon P, Boulin M, Berthier S, Leguy-Seguin V, Martin L, Ciudad M, Janikashvili N, Saas P, Radstake T, Bonnotte B. J Autoimmun; 2017 Feb 20; 77():89-95. PubMed ID: 27863820 [Abstract] [Full Text] [Related]
7. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB. Br J Haematol; 2012 Aug 20; 158(4):539-47. PubMed ID: 22775462 [Abstract] [Full Text] [Related]
8. [Absence of response to rituximab in patients with refractory primary immune thrombocytopenia]. Ma H, Wang Y, Sun L, Gong H. Zhonghua Yi Xue Za Zhi; 2014 Oct 21; 94(38):3011-3. PubMed ID: 25547706 [Abstract] [Full Text] [Related]
15. A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. Zhou H, Xu M, Qin P, Zhang HY, Yuan CL, Zhao HG, Cui ZG, Meng YS, Wang L, Zhou F, Wang X, Li DQ, Bi KH, Zhu CS, Guo CS, Chu XX, Wu QC, Liu XG, Dong XY, Li J, Peng J, Hou M. Blood; 2015 Mar 05; 125(10):1541-7. PubMed ID: 25575541 [Abstract] [Full Text] [Related]
16. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. Mahévas M, Patin P, Huetz F, Descatoire M, Cagnard N, Bole-Feysot C, Le Gallou S, Khellaf M, Fain O, Boutboul D, Galicier L, Ebbo M, Lambotte O, Hamidou M, Bierling P, Godeau B, Michel M, Weill JC, Reynaud CA. J Clin Invest; 2013 Jan 05; 123(1):432-42. PubMed ID: 23241960 [Abstract] [Full Text] [Related]
19. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Jovancevic B, Lindholm C, Pullerits R. Lupus; 2013 Jun 05; 22(7):664-74. PubMed ID: 23612795 [Abstract] [Full Text] [Related]
20. NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia. Ebbo M, Audonnet S, Grados A, Benarous L, Mahevas M, Godeau B, Viallard JF, Piperoglou C, Cognet C, Farnarier C, Harlé JR, Schleinitz N, Vély F. Clin Immunol; 2017 Apr 05; 177():18-28. PubMed ID: 26598010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]